The properties of cannabis have been used in food and herbal medicine for centuries.

MH medical hemp produces and supplies the highest quality cannabis extracts and APIs, made in Germany


Cannabis is among the oldest types of useful and ornamental plants in the world and can be called a true “all-rounder” thanks to its versatility. It is particularly valued as a renewable resource for textiles, paper and building materials and foos, but also as a unique phytopharmaceutical for the treatment of many medical conditions.

MH medical hemp GmbH is an innovative and leading producer of extracts, active phytopharmaceutical ingredients and nutritional supplements, derived from the Cannabis plant.

Products

All of our products and services are always based on the highest quality standards. This means that we guarantee our customers high-quality products which meets even the stringent quality requirements of the pharmaceutical industry. We control the quality from the seed right through to the extracts based on a sophisticated certified quality management system. Our proprietary extraction process ensures the preservation of nearly all beneficial cannabinoids and terpenes while allowing us to eliminate unwanted compounds. This process ensures that our products contain the synergistic compounds necessary to produce the entourage effect which contributes directly to the therapeutic efficacy of Cannabis.

A healthy lifestyle is build upon a well-functioning endocannabinoid system. From essential endocannabimetic regulators like phytocannabinoids to fatty acids, we work towards products which restore and maintain a healthy endocannabinoid system.

Go to article: Home | A New Class of TreatmentGo to article: EditorialGo to article: Pfanstiehl Company InsightGo to article: PfanstiehlGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: DistekGo to article: The pharma industry briefingGo to article: DelSiTechGo to article: Big soil: A $1bn project to develop new drugs from earthGo to article: Novo NordiskGo to article: International Cannabis and Cannabinoid Institute (ICCI) Company InsightGo to article: International Cannabis and Cannabinoid Institute (ICCI)Go to article: medical hempGo to article: Cannabinoids breakthrough signals hope for epilepsy treatment Go to article: CBDepot Company InsightGo to article: CBDepotGo to article: Capsugel Company InsightGo to article: Could cutting out mediators let cancer research off the leash? Go to article: EcocoolGo to article: The next generation of antimalarials Go to article: AlpexGo to article:  Pharma air freight: what does it take to get certified? Go to article: PangeanicGo to article: Blocking generic competition: will naming and shaming work?Go to article: Haselmeier GmbH Company InsightGo to article: Haselmeier GmbH Go to article: EventsGo to article: Abiogen PharmaGo to article: Next issueGo to article: HOF SonderanlagenbauGo to article: EvolveGo to article: ILC Dover Inc